Search Saint Luke's

Tricuspid transcatheter edge-to-edge repair performed better than anticipated in patients expected to have only a modest benefit due to more complex anatomy, the TRILUMINATE trial showed.

Since the first SGLT2 inhibitor drug was approved in 2013, the medications have gone from targeting glucose-lowering to also providing cardiac protection and heart benefits.

Medscape talked to Susie Krug about how virtual nursing is transforming the way Saint Luke's provides care.

May marks Mental Health Awareness Month, a time to come together to raise awareness, reduce stigma, and promote understanding about mental health.

Breast Cancer 
An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer

Through the Havertys' generosity, the Center has been able to create a national model of care called the Cardiometabolic Center Alliance.

Student scholars will spend six weeks shadowing cardiovascular surgeons, researchers, anesthesiologists, critical care physicians, and other collaborative departments.

Meet Mike Main, MD, Senior VP and Chief Clinical Officer at BJC Health System West Region. Learn more about his expert leadership at Saint Luke’s.

Mildred, 107, got up Jan. 27 to eat breakfast at her skilled nursing community in Harrisonville, Missouri, feeling much like herself. Then, suddenly, she struggled to speak. Her right side wouldn’t cooperate. Unable to press the call button, Mildred called out down the hall.

Mindy, a teacher in Blue Springs, has a family history of breast cancer, so it wasn’t a surprise when her doctor recommended she start annual mammograms at the age of 35.